SCHEMBL3417266

SCHEMBL3417266

Cc1cc(-c2ccnc(N)n2)ccc1N1C2CCC1CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ KMO O15229 1/20 0.48
▸ CAMKK2 Q96RR4 1/20 0.44
▸ MAPK14 Q16539 7/20 0.44
▸ PDK1 Q15118 1/20 0.44
▸ PDK2 Q15119 1/20 0.44
▸ PDK3 Q15120 1/20 0.44
▸ PDK4 Q16654 1/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ MAP4K4 O95819 2/20 0.44
▸ CLK4 Q9HAZ1 2/20 0.44
▸ JAK2 O60674 2/20 0.44
▸ CDC7 O00311 1/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ IRAK4 Q9NWZ3 1/20 0.44
▸ AURKA O14965 2/20 0.43
▸ KDR P35968 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417553 0.85 KDM4E (0.42) KDM4EALDH1A1MAPTKMOCAMKK2
SCHEMBL3411485 0.79 HRH4 (0.52) KDM4EALDH1A1MAPTKMOCDK2
SCHEMBL15889921 0.78 KMO (0.60) KDM4EALDH1A1MAPTKMOCAMKK2
SCHEMBL3413852 0.77 MAP3K12 (0.47) —
SCHEMBL31112078 0.76 MAPK14 (0.47) KMOCAMKK2MAPK14CDK2MAP4K4
SCHEMBL22641600 0.74 KMO (0.73) KDM4EALDH1A1MAPTKMOCDK2
SCHEMBL16794218 0.71 KMO (0.53) KDM4EALDH1A1MAPTKMOCAMKK2
SCHEMBL20022604 0.71 KMO (0.53) KDM4EALDH1A1MAPTKMOCAMKK2
SCHEMBL29676670 0.71 KMO (0.53) KDM4EALDH1A1MAPTKMOCAMKK2
SCHEMBL22641581 0.71 KMO (0.73) KDM4EALDH1A1MAPTKMOCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265607-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES Rigel Pharmaceuticals, Inc. (US) 2010-12-29 — — EP disclosed
WO-2009103032-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES RIGEL PHARMACEUTICALS, INC. (US) 2009-08-20 — — WO disclosed
Send feedback